SPIE SA (ENXTPA:SPIE) agreed to acquire 87% stake in Otto Life Science Engineering GmbH on July 17, 2024. The acquisition will be financed with the existing financial resources of SPIE SA. For the period ending December 31, 2023, Otto Life Science Engineering GmbH reported total revenue of ?75 million.

The current management team will remain in place. The deal is subject to customary closing conditions and German antitrust approval. The transaction is expected to complete in in Q3 2024.

The transaction will result in an EPS accretion.